Last: | $1.89 |
---|---|
Change Percent: | -0.31% |
Open: | $1.8958 |
Close: | $1.89 |
High: | $1.93 |
Low: | $1.89 |
Volume: | 7,214 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.89 | $1.8958 | $1.89 | $1.93 | $1.89 | 7,214 | 07-05-2024 |
$1.89 | $1.88 | $1.89 | $1.91 | $1.8501 | 11,571 | 07-04-2024 |
$1.89 | $1.88 | $1.89 | $1.91 | $1.8501 | 11,571 | 07-03-2024 |
$1.906 | $1.8601 | $1.906 | $1.98 | $1.8601 | 25,967 | 07-02-2024 |
$1.901 | $1.9727 | $1.901 | $2.03 | $1.89 | 29,047 | 07-01-2024 |
$1.93 | $1.99 | $1.93 | $1.99 | $1.89 | 6,741 | 06-28-2024 |
$1.86 | $1.89 | $1.86 | $2 | $1.79 | 35,978 | 06-27-2024 |
$1.88 | $1.97 | $1.88 | $2.27 | $1.84 | 66,712 | 06-26-2024 |
$1.93 | $1.93 | $1.93 | $1.96 | $1.93 | 25,872 | 06-25-2024 |
$1.93 | $2.03 | $1.93 | $2.03 | $1.9 | 15,849 | 06-24-2024 |
$2 | $2.03 | $2 | $2.03 | $2 | 6,558 | 06-21-2024 |
$2.04 | $1.9291 | $2.04 | $2.1 | $1.92 | 61,932 | 06-20-2024 |
$1.87 | $1.9 | $1.87 | $1.9299 | $1.86 | 22,605 | 06-19-2024 |
$1.87 | $1.9 | $1.87 | $1.9299 | $1.86 | 22,605 | 06-18-2024 |
$1.8899 | $1.97 | $1.8899 | $2.0681 | $1.815 | 24,763 | 06-17-2024 |
$1.955 | $2.54 | $1.955 | $2.8199 | $1.95 | 95,915 | 06-14-2024 |
$2.5 | $0 | $2.5 | $0 | $0 | 1,163 | 06-11-2024 |
$2.5 | $2.57 | $2.5 | $2.62 | $2.5 | 11,707 | 06-06-2024 |
$2.58 | $2.75 | $2.58 | $2.84 | $2.58 | 19,575 | 06-05-2024 |
$2.52 | $2.72 | $2.52 | $2.72 | $2.46 | 30,781 | 06-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Fully underwritten Retail Entitlement Offer to open at 9:00 am (Melbourne time) on 19 June 2024 Retail Entitlement Offer to raise approximately A$55.0m (US$36.9m 1 ) will close at 5:00 pm (Melbourne time) on 10 July 2024 Prospectus and personalized application ...
Fully underwritten Retail Entitlement Offer to raise a further approximately A$55.9m (US$36.9m 1 ) will open on 19 June 2024 and close at 5:00 pm (Melbourne time) on 10 July 2024 MELBOURNE, Australia and PRINCETON, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ...
Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2 calendar year 2025, and anticipated for ShORe in mid-calendar year 2025 MELBOURNE, Au...